1-2 of 2
Hussain Saba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is Reversed by Decitabine Therapy-Results of a Phase III Randomized Study.

Lanlan Shen, MD, PhD, Hagop Kantarjian, MD, Hussain Saba, MD, E. Lin, Don Berry, Saira Ahmed, Jaroslav Jelinek, MD, Jean-Pierre J. Issa, MD
Journal: Blood
Blood (2005) 106 (11): 790.
https://doi.org/10.1182/blood.V106.11.790.790
Published: 2005
Journal Articles

First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS).

Hussain Saba, Craig Rosenfeld, Jean-Pierre Issa, John DiPersio, Azra Raza, Virginia Klimek, James Slack, Carlos de Castro, Karl Mettinger, Hagop Kantarjian
Journal: Blood
Blood (2004) 104 (11): 67.
https://doi.org/10.1182/blood.V104.11.67.67
Published: 2004